MCPH1 inhibits condensin II during interphase by regulating its SMC2-kleisin interface
- University of Oxford, United Kingdom
- The Institute of Cancer Research, United Kingdom
- Baylor College of Medicine, United States
- Human Technopole, Italy
Abstract
The dramatic change in morphology of chromosomal DNAs between interphase and mitosis is one of the defining features of the eukaryotic cell cycle. Two types of enzymes, namely cohesin and condensin confer the topology of chromosomal DNA by extruding DNA loops. While condensin normally configures chromosomes exclusively during mitosis, cohesin does so during interphase. The processivity of cohesin’s loop extrusion during interphase is limited by a regulatory factor called WAPL, which induces cohesin to dissociate from chromosomes via a mechanism that requires dissociation of its kleisin from the neck of SMC3. We show here that a related mechanism may be responsible for blocking condensin II from acting during interphase. Cells derived from patients affected by microcephaly caused by mutations in the MCPH1 gene undergo premature chromosome condensation but it has never been established for certain whether MCPH1 regulates condensin II directly. We show that deletion of Mcph1 in mouse embryonic stem cells unleashes an activity of condensin II that triggers formation of compact chromosomes in G1 and G2 phases, which is accompanied by enhanced mixing of A and B chromatin compartments, and that this occurs even in the absence of CDK1 activity. Crucially, inhibition of condensin II by MCPH1 depends on the binding of a short linear motif within MCPH1 to condensin II's NCAPG2 subunit. We show that the activities of both Cohesin and Condensin II may be restricted during interphase by similar types of mechanisms as MCPH1's ability to block condensin II's association with chromatin is abrogated by the fusion of SMC2 with NCAPH2. Remarkably, in the absence of both WAPL and MCPH1, cohesin and condensin II transform chromosomal DNAs of G2 cells into chromosomes with a solenoidal axis showing that both cohesin and condensin must be tightly regulated to adjust the structure of chromatids for their successful segregation.
Data availability
HiC sequencing data has been deposited in GEO. (accession number: GSE188988)
-
MCPH1 inhibits condensin II during interphase by regulating its SMC2-kleisin interfaceNCBI Gene Expression Omnibus, GSE188988.
Article and author information
Author details
Lothar Schermelleh
Alessandro Vannini
Funding
Wellcome Trust (107935/Z/15/Z)
- Martin Houlard
- Jonathan Godwin
- Kim Nasmyth
McNair Medical Institute Scholar Award
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
NIH Encyclopedia of DNA Elements Mapping Center Award (UM1HG009375)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
US-Israel Binational Science Foundation Award (2019276)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
Behavioral Plasticity Research Institute (NSF DBI-2021795)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
NSF Physics Frontiers Center Award (NSF PHY-2019745)
- Muhammad S Shamim
- Aviva Presser Aiden
- Erez Lieberman-Aiden
- Lothar Schermelleh
NIH CEGS Award (RM1HG011016-01A1)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
European Research Council (294401)
- Martin Houlard
- Jonathan Godwin
- Kim Nasmyth
Cancer Research UK (26747)
- Martin Houlard
- Jonathan Godwin
- Kim Nasmyth
Wellcome Trust (107457/Z/15/Z)
- Lothar Schermelleh
Wellcome Trust (091911)
- Lothar Schermelleh
Paul and Daisy Soros Foundation
- Muhammad S Shamim
Cancer Research UK (CR-UK C47547/A21536)
- Erin E Cutts
- Alessandro Vannini
Wellcome Trust (200818/Z/16/Z)
- Erin E Cutts
- Alessandro Vannini
Welch Foundation (Q-1866)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#08-133) of the University of Arizona. The protocol was approved by the Committee on the Ethics of Animal Experiments of the University of Minnesota (Permit Number: 27-2956). All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.
Copyright
© 2021, Houlard et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,816
- views
-
- 414
- downloads
-
- 28
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
MCPH1 inhibits condensin II during interphase by regulating its SMC2-kleisin interface
eLife 10:e73348.
https://doi.org/10.7554/eLife.73348
Further reading
-
- Biochemistry and Chemical Biology
- Stem Cells and Regenerative Medicine
Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.
